Repression of NR4A1 by a chromatin modifier promotes docetaxel resistance in PC-3 human prostate cancer cells

FEBS Letters

Volumn 587, Issue 16, 2013, Pages 2542-2551

  Yu, Liang ^a,b   Su, Yan Sheng ^a,c   Zhao, Jie ^d   Wang, He ^a   Li, Wei ^d  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Third Hospital of PLA   (China)

^c No 323 Hospital of PLA   (China)

^d FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

(NuRD) complex; Chemoresistance; Metastasis associated protein 1 (MTA1); Nucleosome remodeling deacetylation; Prostate cancer (PCa)

Indexed keywords

COREPRESSOR PROTEIN; DOCETAXEL; HISTONE DEACETYLASE; HISTONE DEACETYLASE 2; NUCLEAR RECEPTOR NUR77; PREDNISOLONE; PROTEIN MTA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; ENZYME REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PROTEIN INTERACTION; REPEATED DRUG DOSE; UPREGULATION;

CHEMORESISTANCE; METASTASIS-ASSOCIATED PROTEIN 1 (MTA1); NUCLEOSOME REMODELING DEACETYLATION (NURD) COMPLEX; PROSTATE CANCER (PCA);

ANIMALS; APOPTOSIS; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; CHROMATIN; DRUG RESISTANCE, NEOPLASM; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASE 2; HISTONE DEACETYLASES; HUMANS; MALE; MI-2 NUCLEOSOME REMODELING AND DEACETYLASE COMPLEX; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; PROSTATIC NEOPLASMS; PROTEIN BINDING; REPRESSOR PROTEINS; TAXOIDS; TRANSCRIPTION, GENETIC;

EID: 84881476164     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.06.029     Document Type: Article

References (40)

1. L. Zhang, B.X. Yang, H.T. Zhang, J.G. Wang, H.L. Wang, and X.J. Zhao Prostate cancer: an emerging threat to the health of aging men in Asia Asian J. Androl. 13 2011 574 578
2. B. Seruga, and I.F. Tannock Chemotherapy-based treatment for castration-resistant prostate cancer J. Clin. Oncol. 29 2011 3686 3694
3. H. Miyake, I. Sakai, K. Harada, M. Muramaki, and M. Fujisawa Significance of docetaxel-based chemotherapy as treatment for metastatic castration-resistant prostate cancer in Japanese men over 75 years old Int. Urol. Nephrol. 44 2012 1697 1703
4. N. Fujimoto, M. Shiota, T. Kubo, and T. Matsumoto Novel therapeutic strategies following docetaxel-based chemotherapy in castration-resistant prostate cancer Expert Rev. Clin. Pharmacol. 3 2010 785 795
5. W.X. Qi, Z. Shen, and Y. Yao Docetaxel-based therapy with or without estramustine as first-line chemotherapy for castration-resistant prostate cancer: a meta-analysis of four randomized controlled trials J. Cancer Res. Clin. Oncol. 137 2011 1785 1790
6. L. Gan, J. Wang, H. Xu, and X. Yang Resistance to docetaxel-induced apoptosis in prostate cancer cells by p38/p53/p21 signaling Prostate 71 2011 1158 1166
7. E. Cengiz Overcoming drug resistance in hormone- and drug-refractory prostate cancer cell line, PC-3 by docetaxel and gossypol combination Mol. Biol. Rep. 37 2010 1269 1277
8. D.Q. Li, S.B. Pakala, S.S. Nair, J. Eswaran, and R. Kumar Metastasis-associated protein 1/nucleosome remodeling and histone deacetylase complex in cancer Cancer Res. 72 2012 387 394
9. Y. Toh, and G.L. Nicolson The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications Clin. Exp. Metastasis 26 2009 215 227
10. M.D. Hofer The role of metastasis-associated protein 1 in prostate cancer progression Cancer Res. 64 2004 825 829
11. H. Wang Akt mediates metastasis-associated gene 1 (MTA1) regulating the expression of E-cadherin and promoting the invasiveness of prostate cancer cells PLoS One 7 2012 e46888
12. S.D. Reddy, S.B. Pakala, P.R. Molli, N. Sahni, N.K. Karanam, P. Mudvari, and R. Kumar Metastasis-associated protein 1/histone deacetylase 4-nucleosome remodeling and deacetylase complex regulates phosphatase and tensin homolog gene expression and function J. Biol. Chem. 287 2012 27843 27850
13. K. Li, S.J. Dias, A.M. Rimando, S. Dhar, C.S. Mizuno, A.D. Penman, J.R. Lewin, and A.S. Levenson Pterostilbene acts through metastasis-associated protein 1 to inhibit tumor growth, progression and metastasis in prostate cancer PLoS One 8 2013 e57542
14. L. Kai Targeting prostate cancer angiogenesis through metastasis-associated protein 1 (MTA1) Prostate 71 2011 268 280
15. L. Kai, S.K. Samuel, and A.S. Levenson Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex Int. J. Cancer 126 2010 1538 1548
16. H.M. Mohan, C.M. Aherne, A.C. Rogers, A.W. Baird, D.C. Winter, and E.P. Murphy Molecular pathways: the role of NR4A orphan nuclear receptors in cancer Clin. Cancer Res. 18 2012 3223 3228
17. H. Uemura, and C. Chang Antisense TR3 orphan receptor can increase prostate cancer cell viability with etoposide treatment Endocrinology 139 1998 2329 2334
18. A.J. Deutsch, H. Angerer, T.E. Fuchs, and P. Neumeister The nuclear orphan receptors NR4A as therapeutic target in cancer therapy Anticancer Agents Med. Chem. 12 2012 1001 1014
19. K.L. Mahon, S.M. Henshall, R.L. Sutherland, and L.G. Horvath Pathways of chemotherapy resistance in castration-resistant prostate cancer Endocr. Relat. Cancer 18 2011 R103 R123
20. K. Kojima, R. Ohhashi, Y. Fujita, N. Hamada, Y. Akao, Y. Nozawa, T. Deguchi, and M. Ito A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells Biochem. Biophys. Res. Commun. 373 2008 423 428
21. S.A. Kang, H. Na, H.J. Kang, S.H. Kim, M.H. Lee, and M.O. Lee Regulation of Nur77 protein turnover through acetylation and deacetylation induced by p300 and HDAC1 Biochem. Pharmacol. 80 2010 867 873
22. A. Billis, M.S. Guimaraes, L.L. Freitas, L. Meirelles, L.A. Magna, and U. Ferreira The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies J. Urol. 180 2008 548 552 discussion 552-3
23. S.M. Falzarano, and C. Magi-Galluzzi Prostate cancer staging and grading at radical prostatectomy over time Adv. Anat. Pathol. 18 2011 159 164
24. A.J. O'Neill Characterisation and manipulation of docetaxel resistant prostate cancer cell lines Mol. Cancer 10 2011 126
25. W. Li, W. Bao, J. Ma, X. Liu, R. Xu, R.A. Wang, and Y. Zhang Metastasis tumor antigen 1 is involved in the resistance to heat stress-induced testicular apoptosis FEBS Lett. 582 2008 869 873
26. K. Kurakula, E. van der Wal, D. Geerts, C.M. van Tiel, and C.J. de Vries FHL2 protein is a novel co-repressor of nuclear receptor Nur77 J. Biol. Chem. 286 2011 44336 44343
27. X. Sun Distinct transcriptional regulation and function of the human BACE2 and BACE1 genes FASEB J. 19 2005 739 749
28. J. Jongsma, M.H. Oomen, M.A. Noordzij, W.M. Van Weerden, G.J. Martens, T.H. van der Kwast, F.H. Schroder, and G.J. van Steenbrugge Kinetics of neuroendocrine differentiation in an androgen-dependent human prostate xenograft model Am. J. Pathol. 154 1999 543 551
29. S. Zhang Sertoli cell-specific expression of metastasis-associated protein 2 (MTA2) is required for transcriptional regulation of the follicle-stimulating hormone receptor (FSHR) gene during spermatogenesis J. Biol. Chem. 287 2012 40471 40483
30. D. Kim, C.W. Gregory, F.S. French, G.J. Smith, and J.L. Mohler Androgen receptor expression and cellular proliferation during transition from androgen-dependent to recurrent growth after castration in the CWR22 prostate cancer xenograft Am. J. Pathol. 160 2002 219 226
31. X.Z. Wang, J.R. Beebe, L. Pwiti, A. Bielawska, and M.J. Smyth Aberrant sphingolipid signaling is involved in the resistance of prostate cancer cell lines to chemotherapy Cancer Res. 59 1999 5842 5848
32. K. Akasaka, C. Maesawa, M. Shibazaki, F. Maeda, K. Takahashi, T. Akasaka, and T. Masuda Loss of class III beta-tubulin induced by histone deacetylation is associated with chemosensitivity to paclitaxel in malignant melanoma cells J. Invest. Dermatol. 129 2009 1516 1526
33. L.Y. Bourguignon, W. Xia, and G. Wong Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells J. Biol. Chem. 284 2009 2657 2671
34. D.Q. Li, K. Ohshiro, S.D. Reddy, S.B. Pakala, M.H. Lee, Y. Zhang, S.K. Rayala, and R. Kumar E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1 Proc. Natl. Acad. Sci. USA 106 2009 17493 17498
35. Y. Sun E3 ubiquitin ligases as cancer targets and biomarkers Neoplasia 8 2006 645 654
36. S.D. Reddy, S.B. Pakala, K. Ohshiro, S.K. Rayala, and R. Kumar MicroRNA-661, a c/EBPalpha target, inhibits metastatic tumor antigen 1 and regulates its functions Cancer Res. 69 2009 5639 5642
37. I.P. Pogribny, J.N. Filkowski, V.P. Tryndyak, A. Golubov, S.I. Shpyleva, and O. Kovalchuk Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin Int. J. Cancer 127 2010 1785 1794
38. Y.G. Yoo, G. Kong, and M.O. Lee Metastasis-associated protein 1 enhances stability of hypoxia-inducible factor-1alpha protein by recruiting histone deacetylase 1 EMBO J. 25 2006 1231 1241
39. D. Sankaran Mechanism of MTA1 protein overexpression-linked invasion: MTA1 regulation of hyaluronan-mediated motility receptor (HMMR) expression and function J. Biol. Chem. 287 2012 5483 5491
40. S.J. Guo, Z.J. Sun, and W. Li New insights about the early diagnosis of fertility impairment in varicoceles: the DNA repair gene example Med. Hypotheses 78 2012 536 538